Elsevier further liberalizes copyright for authors

Policy now allows for final version web posting.

Amsterdam, 3 June, 2004 - Authors of papers published in any Elsevier journal can now post the final text of their articles, as accepted by the journal, i.e. with all of the changes made during the peer-review and editing process, on the authors' personal or their institutions’ web sites. 

For several years, Elsevier has permitted the posting of pre-print versions of articles without requiring permission. Now, no permission is required for authors to revise and widely post the final version of the text, provided that the posting contains a link to the home page of the journal in which the article was published, and that the posting is not used for commercial purposes -- such as systematic distribution or creating links for commercial customers to articles. However, to preserve the integrity of the official record of publication, the final published version as it appears in the journal (PDF and HTML) will continue to be available only on an Elsevier site.

"Elsevier's policy on author postings clearly supports scholarly communications. We have a strong history of allowing authors to use their Elsevier-published articles within their institutions for teaching and sharing with colleagues, and to create derivative works.

"Several years ago, we supported the development of pre-print servers by deciding papers posted to such servers would not be viewed as 'prior submissions.' Furthermore, following Elsevier's publication of papers, we have not required the removal of pre-print versions from pre-print servers. But we have gone even further than that: for several years we have permitted authors to post their final version as accepted on secure, internal institutional networks. Today, we have taken an important step, which demonstrates our continued support for scholarly communications.

"We are not only announcing the extension or further liberalization of our policy, we are also reaffirming prior policy, to ensure that our authors' needs are being met," said Arie Jongejan, CEO, Science and Technology, Elsevier.

Additional Information:

The June issue of the SPARC Open Access Newsletter, Issue #74 contains interesting comments on Elsevier’s policy revision.

About Elsevier
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com